Journal of Capital Medical University ›› 2013, Vol. 34 ›› Issue (2): 187-190.doi: 10.3969/j.issn.1006-7795.2013.02.005

Previous Articles     Next Articles

Biomarkers in predicting renal replacement therapy in acute septic kidney injury

JIANG Bo, JIANG Li, XI Xiuming   

  1. Intensive Care Unit, Fuxing Hospital, Capital Medical University, Beijing 100038, China
  • Received:2013-01-16 Online:2013-04-21 Published:2013-04-17
  • Supported by:

    This study was supported by Scientific Research Foundation of Capital Medical University(2009-3190).

Abstract:

Objective To evaluate whether the serum neutrophil gelatinase associated lipocalin(sNGAL), urinary neutrophil gelatinase lipocalin(uNGAL), urinary interleukin-18(uIL-18) or urinary kidney injury molecule-1(uKIM-1) can predict the need for renal replacement therapy(RRT)in patients with septic acute kidney injury(AKI). Methods A prospective observational study was conducted in patients with septic AKI whose expected ICU stay ≥24 h. AKI was defined by American Kidney Injury(AKIN) criteria during the 48 h after admission, while sNGAL, uNGAL, uIL-18 and uKIM-1 were determined at the enrollment. Test characteristics were calculated to assess the diagnostic performance of these biomarkers. Results Forty-five patients were studied, RRT was initiated in 12 patients with septic AKI in the first 7 days. Two groups were defined according to the need of RRT: RRT group(n=12) and non-RRT group(n=33). RRT group had higher median uNGAL level compared to non-RRT group(912.0 vs 218.0 ng/mL, P<0.001). The predicting performance for uNGAL was good(AUC 0.88), and that of sNGAL, uIL-18 and uKIM-1 was poor(AUC 0.68,0.69,0.67, respectively). Conclusion uNGAL might be a good biomarker for predicting the need of RRT in patients with septic AKI.

Key words: sepsis, acute kidney injury, renal replacement therapy, neutrophil gelatinase associated lipocalin, kidney injury molecule-1, interleukin-18

CLC Number: